Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction.
Publication
, Journal Article
Greene, SJ; Fonarow, GC
Published in: Eur Heart J
August 14, 2023
Duke Scholars
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
August 14, 2023
Volume
44
Issue
31
Start / End Page
2994 / 2997
Location
England
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Greene, S. J., & Fonarow, G. C. (2023). Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction. Eur Heart J, 44(31), 2994–2997. https://doi.org/10.1093/eurheartj/ehad427
Greene, Stephen J., and Gregg C. Fonarow. “Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction.” Eur Heart J 44, no. 31 (August 14, 2023): 2994–97. https://doi.org/10.1093/eurheartj/ehad427.
Greene SJ, Fonarow GC. Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction. Eur Heart J. 2023 Aug 14;44(31):2994–7.
Greene, Stephen J., and Gregg C. Fonarow. “Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction.” Eur Heart J, vol. 44, no. 31, Aug. 2023, pp. 2994–97. Pubmed, doi:10.1093/eurheartj/ehad427.
Greene SJ, Fonarow GC. Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction. Eur Heart J. 2023 Aug 14;44(31):2994–2997.
Published In
Eur Heart J
DOI
EISSN
1522-9645
Publication Date
August 14, 2023
Volume
44
Issue
31
Start / End Page
2994 / 2997
Location
England
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology